SESEN BIO, INC Net Income 2012-2021 | SESN

SESEN BIO, INC net income from 2012 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
SESEN BIO, INC Annual Net Income
(Millions of US $)
2020 $-23
2019 $-108
2018 $-34
2017 $-29
2016 $2
2015 $-33
2014 $-35
2013 $-22
2012 $-23
2011 $-14
SESEN BIO, INC Quarterly Net Income
(Millions of US $)
2021-09-30 $72
2021-06-30 $-25
2021-03-31 $-56
2020-12-31 $-15
2020-09-30 $-23
2020-06-30 $-26
2020-03-31 $42
2019-12-31 $-34
2019-09-30 $-13
2019-06-30 $-54
2019-03-31 $-6
2018-12-31 $-7
2018-09-30 $-14
2018-06-30 $-9
2018-03-31 $-4
2017-12-31 $-7
2017-09-30 $-9
2017-06-30 $-7
2017-03-31 $-6
2016-12-31 $-4
2016-09-30 $19
2016-06-30 $-6
2016-03-31 $-8
2015-12-31 $-10
2015-09-30 $-10
2015-06-30 $-7
2015-03-31 $-7
2014-12-31 $-8
2014-09-30 $-11
2014-06-30 $-8
2014-03-31 $-8
2013-12-31 $-5
2013-09-30 $-5
2013-06-30 $-5
2013-03-31 $-6
2012-12-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.148B $0.011B
Sesen Bio Inc. is a late-stage company developing next-generation antibody-drug conjugate therapies for patients with cancer. The company's product portfolio includes Vicinium(TM) which is in its clinical trial, treats high-grade non-muscle invasive bladder cancer. Sesen Bio Inc., formerly known as Eleven Biotherapeutics, is based in Massachusetts, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.033B 9.10
Bio-Rad Laboratories (BIO.B) United States $17.971B 36.47
QIAGEN (QGEN) Netherlands $11.044B 18.70
Biohaven Pharmaceutical Holding (BHVN) United States $7.729B 0.00
Emergent Biosolutions (EBS) United States $2.541B 9.14
Arcus Biosciences (RCUS) United States $2.414B 0.00
Myovant Sciences (MYOV) United Kingdom $1.374B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.167B 0.00
Zymeworks (ZYME) Canada $0.623B 0.00
Ambrx Biopharma (AMAM) United States $0.231B 0.00
SQZ Biotechnologies (SQZ) United States $0.214B 0.00
Enzo Biochem (ENZ) United States $0.161B 20.75